genetic metabolic diseases
Inborn errors of metabolism are characterized by dysregulation of the metabolic networks that underlie development and homeostasis, and constitute an important and expanding group of genetic disorders in humans.
Types (summary)
Disorders of carbohydrate metabolism
- E.g., glycogen storage disease (E74.0)
Disorders of amino acid metabolism
- E.g., phenylketonuria (E70.0), maple syrup urine disease (E71.0), glutaric acidemia type 1
Disorders of organic acid metabolism (organic acidurias)
- E.g., alcaptonuria (E70.2)
Disorders of fatty acid oxidation and mitochondrial metabolism
- E.g., medium chain acyl dehydrogenase deficiency (glutaric acidemia type 2)
Disorders of porphyrin metabolism
- E.g., acute intermittent porphyria (E80.2)
Disorders of purine or pyrimidine metabolism
- E.g., Lesch-Nyhan syndrome (E79.1)
Disorders of steroid metabolism
- E.g., congenital adrenal hyperplasia (E25.0)
Disorders of mitochondrial function
- E.g., Kearns-Sayre syndrome (H49.8)
Disorders of peroxisomal function
- E.g., Zellweger syndrome (Q87.8)
Lysosomal storage disorders
- E.g., Gaucher’s disease (E75.22)
Types (developed)
I. Defects in metabolism of amino acids
Phenylalanine
Tyrosine metabolism defects
- Tyrosinemia type I
- Tyrosinemia type II
- Transient tyrosinemia of the newborn
- Hawkinsinuria
- Albinism
- Alcaptonuria
Sulfur-containing amino acids metabolism defects
- Methionine
- Homocystinemia (Homocystinuria)
- Homocystinemia type I
- Homocystinemia type II
- Homocystinemia type III
- Hypermethioninemia
- Cystathioninemia
- Cysteine/Cystine
- Cystinuria
- Cystinosis
- Sulfite oxidase deficiency
- beta-mercaptolate-cysteine disulfiduria
- taurinuria
Tryptophane
- Hartnup disease
- Serotonin deficiency
- Tryptophanemia
- Kynureninuria
- Kynureninase defects - Hydroxykynureninuria
- Pyridoxine-responsive xanthurenic aciduria
- Organic acidemias
- Indicanuria - tryptophane malapsorption
- Hydincuria
- Indolylacroylglycynuria
- Glutaric aciduria type 1
Valine, Leucine, Isoleucine and related organic acidemias
Glycine
Serine
Threonine
Proline - Hydroxyproline
Glutamic acid
Urea cycle (hyperammonemia) (Arginine, Citrulline, Ornithine)
- déficit en ornithine transcarbamylase
- déficit en carbamyl phophate synthétase
- ornitinémie
- citrullinémie
- acidurie argininosuccinique
- cystinosis
- homocystinuria (déficit en cystathionine beta-synthase)
Histidine
Beta-amino acids
Lysine
Acide aspartique
- Aspartylglucosaminurie
II. inherited disorders of lipid metabolism
A. Anomalies of fatty acid beta oxidation
B. Anomalies of very long chain fatty acids (peroxysomal diseases)
Group 1. Anbormal peroxysomes (multiple enzymatic deficiency)
- Zellweger disease
- neonatal adrenoleukodystrophy
- infantile REfsum disease
- pipecolic acidemia
Group 2. Normal peroxysome. Isolated enzymatic deficiency
- X-linked adrenoleucodystrophy
- acatalasemia
- hyperoxaluria type 1
- 3-oxoacyl-CoA thiolase deficiency (syndrome de pseudo-Zellweger)
- acyl-CoA oxidase deficiency
- bi-fonctionnal enzyme deficiency
- dihydroxy-acetone-phosphate acetyl-transférase deficiency
— c. Groupe 3. Peroxysomes présents mais structure anormale. Déficits enzymatiques multiples.
- Chondrodysplasie ponctuée rhizomélique
- Syndrome de Zellweger-like
C. Lipid lysosomal storage diseases (lipidoses)
sphingolipidosis
- ceramidosis
- glycosylceramide lipidosis (maladie de Gaucher)
- ceramidase (Farber disease ou Farber lipogranulomatosis)
- glycosphingolipidosis
- Fabry disease
- gangliosidosis type I (GM1)
- gangliosidosis type II (GM2)
- type I (maladie de Tay-Sachs)
- type II (maladie de Sandhoff)
- phosphosphingolipidosis
- sphingomyeline-cholesterol lipidosis (Niemann-Pick disease) (MIM.257200)
- Niemann-Pick type A disease (MIM.257200)
- Niemann-Pick type B disease (MIM.257200)
- Niemann-Pick type C disease (MIM.257220)
- Niemann-Pick type C1 disease (MIM.257220)
- Niemann-Pick type C2 disease - deficiency of HE1 (human epididymis-1) (MIM.601015)
- sphingomyeline-cholesterol lipidosis (Niemann-Pick disease) (MIM.257200)
- Niemann-Pick type D disease
- Niemann-Pick type E disease (MIM.257200)
- alpha-N-acétylgalactosaminidase disease (Schindler disease)
- metachromatic leucodystrophy (sulphatide lipidosis)
- sulfatase mutiple deficiency
- Krabbe disease
- Batten disease
- Wolman disease (lysosomal lipase acide deficiency)
- cholestérol esters storage disease
- fucosidosis
D. Anomalies du métabolisme et du transport des lipoprotéines
1. hypercholestérolémie familiale
— hétérozygote
— homozygote
2. Déficit familial en Apo B-100
3. Hyperlipidémie combinée familiale
4. Hyperapobetalipoprotéinémie familiale
5. Elévation du Lp(a)
6. Dysbétalipoprotéinémie familiale
7. Sitostérolémie (Phytostérolémie)
8. Hypertriglycéridémie familiale (FHTG)
9. Hyperchylomicronémies
— Déficit en lipoprotéine lipas (LPL)
— Déficit en apoC-II (co-facteur du LPL)
— Hyperlipoprotéinémie familiale de type 5
10. Déficits en HDL
— déficit familial en HDL (High Density Lipoprotein) (maladie de Tangier)
— Déficit en lécithine-cholestérol acyltransférase (LCAT)
11. Abetalipoprotéinémie et hypobetalipoprotéinémie
12. Xanthomatose cérébro-tendineuse
13. Autres anomalies lipidiques
— Hépatostéatose familiale
— Lipodystrophie totale congénitale
III. Defects in metabolism of carbohydrates
Intestinal defects of carbohydrate metabolism
Defetcs in intermediary carbohydrate metabolism
Defetcs without lactic acidosis or abnormal glycogen storage
— Anomalies du métabolisme du galactose
— Anomalies du métabolisme du fructose
Anomalies du métabolisme intermédiaire des glucides avec acidose lactique
Maladie du stockage du glycogène (Glycogénoses)
GSD O
GSD Ia
GSD Ib
GSD Ic
GSD IIa et IIb
GSD III
GSD IV - Amylopectinosis
GSD V
GSD VI
GSD VII
GSD VIII
GSD IX a,b,c
GSD X
GSD IX
F. Déficit en Xylulose déshydrogénase
G. Déficit en alpha-mannosidase acide (Mannosidose)
déficit en alpha-fucosidase acide (Fucosidose)
H. Maladie de Lafora
IV. Anomalies du métabolisme des mucopolysaccharides (Mucopolysaccharidosis ou glycprotéinoses)
A. Maladie de Hurler (Mucopolysaccharidosis IH)
B. Maladie de Scheie (Mucopolysaccharidosis IS)
C. Maladie de Hurler-Scheie (Mucopolysaccharidosis IH-IS)
D. Maladie de Hunter (Mucopolysaccharidosis II)
type A
type B
E. Maladie de Sanfilippo (Mucopolysaccharidosis III) (types A, B, C, D)
F. Maladie de Morquio (Mucopolysaccharidosis IV) (types A, B)
G. Kératane et Héparane sulfaturie (Mucopolysaccharidosis VIII)
H. Maladie de Maroteaux-Lamy (Mucopolysaccharidosis VI) (mild and severe type)
I. Beta-glucuronidase deficiency (Mucopolysaccharidosis VI, Sly’s syndrome)
V. Anomalies du métabolisme des mucolipides (Mucolipidosis)
Mucoplipidosis type I (ML-1) ou lipomucopolysaccharidose ou sialidose de type 2 infantile
Mucoplipidosis type II (ML-2) (Leroy I-cell syndrome)
Mucoplipidosis type III (ML-3) (Pseudo-Hurler polydystrophy syndrome)
Mucoplipidosis type IV (ML-4)
VI. Anomalies of purines and pyrimidines metabolism
Gout
Lesh-Nyhan disease
Hypouricémie
Xanthinurie
Déficit en adénosine déaminase
Déficit en nucléoside phosphorylase
Déficit en adénine phosphoribosyltransférase
Acidurie orotique
VII. Anomalies du métabolisme des porphyrines (heme metabolism) (Porphyrias)
Hepatic porphyrias
porphyrie aigue intermittente
porphyrie cutanée tardive
Erythropoietic porphyrias
protoporphyrie érythropoiétique
VIII. Anomalies du métabolisme des métaux
cuivre
— Maladie de Wilson
fer
— Hémochromatose constitutionnelle
IX. Anomalies of oxidative phosphorylation (OXPHOS)
Defects in structural OXPHOS genes
Faulty intergenomic communication
OXPHOS assembly, homeostasis and import defects
Mitochondrial cytopathy
IX. Anomalies vitaminiques
X. Anomalies des folates
déficit en 5,10-@Methylenetetrahydrofolate reductase (MTHFR) (omim)
References
Abramovich CM, Prayson RA, McMahon JT, Cohen BH.Ultrastructural examination of the axillary skin biopsy in the diagnosis of metabolic diseases.Hum Pathol. 2001 Jun;32(6):649-55. PMID: 11431721
Reviews
Lanpher B, Brunetti-Pierri N, Lee B. Inborn errors of metabolism: the flux from Mendelian to complex diseases. Nat Rev Genet. 2006 Jun;7(6):449-60. PMID: 16708072
Barness LA. An approach to the diagnosis of metabolic diseases. Fetal Pediatr Pathol. 2004 Jan;23(1):3-10. PMID: 15371119
Boneh A. A model for PKC involvement in the pathogenesis of inborn errors of metabolism. Trends Mol Med. 2002 Nov;8(11):524-31. PMID: 12421686
Abramovich CM, Prayson RA, McMahon JT, Cohen BH. Ultrastructural examination of the axillary skin biopsy in the diagnosis of metabolic diseases. Hum Pathol. 2001 Jun;32(6):649-55. PMID: 11431721
Burton BK. Inborn errors of metabolism in infancy: a guide to diagnosis. Pediatrics. 1998 Dec;102(6):E69. PMID: 9832597